Necroptosis Inhibitors For The Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract

Abstract

The invention relates to necroptosis inhibitors for the treatment of inflammatory diseases of the gastrointestinal tract. Particularly, the invention relates to inhibitors of the receptor-interacting protein-1 /receptor-interacting protein-3 (RIP1/RIP3) complex, for the treatment of inflammatory diseases or conditions of the gastrointestinal tract, in particular inflammatory bowel disease.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jan 31, 2013
  • Application: Jul 26, 2012
    WO EP 2012003173 W
  • Priority: Jul 27, 2011
    DE DE 102011109159 A

Download Citation


Sign in to the Lens

Feedback